Clinical Trials Browser

INDUSTRY × Hematologic Neoplasms × camrelizumab × Clear all

NCT02492789 2019-09-30

A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms